DENVER and GOLDEN, Colo., Nov. 2 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today the company's continued participation at the 37th Annual Society for Neuroscience Meeting in San Diego, California, November 3 - 7, 2007.
After the wildfires of the past week and a half, the influx of meeting participants will hopefully provide a much needed boost to the hard hit economy of the region. "All of the staff at ABR-Affinity BioReagents is hopeful that those in San Diego and the surrounding area who have been displaced by the fires will be able to rebuild and resume their lives as soon as possible. They have our deepest sympathy," said Ken Wilczek, President of ABR.
ABR now offers over 2,600 products for neurobiological research, many of them new since last year's meeting, all of which are supported by ABR's 100% Quality Guarantee. Emerging research on the brain and the nervous system involves overlapping research areas, including vision, nitric oxide synthase, signal transduction and ion transport and regulation. "This is a critical research field, and ABR is proud to be a leading contributor to advances in understanding the nervous system and associated disorders," noted Mr. Wilczek. With attendance predicted to top 30,000 researchers, this is one of the largest meetings in the biotechnology arena. ABR-Affinity BioReagents will be located at booth # 3612 at the upcoming meeting.
About ABR-Affinity BioReagents
Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).
With more than 35,000 antibodies focused in 43 research areas, ABR
offers a unique value proposition in the life science industry -- research
antibodies that are 100% quality guaranteed or your money
|SOURCE ABR-Affinity BioReagents|
Copyright©2007 PR Newswire.
All rights reserved